Presentation is loading. Please wait.

Presentation is loading. Please wait.

Egyptian Perspective On Prediabetes & Diabetes Ibrahim El Ebrashy Prof. Of Internal Medicine & Diabetes Faculty Of Medicine-Cairo University Dean National.

Similar presentations


Presentation on theme: "Egyptian Perspective On Prediabetes & Diabetes Ibrahim El Ebrashy Prof. Of Internal Medicine & Diabetes Faculty Of Medicine-Cairo University Dean National."— Presentation transcript:

1 Egyptian Perspective On Prediabetes & Diabetes Ibrahim El Ebrashy Prof. Of Internal Medicine & Diabetes Faculty Of Medicine-Cairo University Dean National Institute Of Diabetes & Endocrinology (NIDE ) Cairo – MOH Egypt

2 Top 10 prevalence of diabetes (20-79 age groups) in 2007 (With 2025 prevalence) Nauru UAE Saudi Arabia Bahrain Kuwait Oman Tonga Mauritius Egypt Mexico Prevalence (%) Country International Diabetes Federation. Diabetes Atlas. Brussels, Belgium: IDF; 2007

3 Preventing CHRONIC DISEASES a vital investment World Health Organization 2007

4 The burden and costs of chronic diseases in low-income and middle-income countries The Lancet, 5 December 2007

5 They estimated the burden and loss of economic output associated with chronic diseases in 23 selected countries These countries were selected as leading countries collectively accounting for around 80% of the total mortality burden attributable to chronic diseases in developing countries.

6 They aggregate estimates from coronary heart disease, stroke, and diabetes, since these disorders represent the greatest burden of the entire group of chronic diseases. All estimates are projected between 2005 and 2015.

7

8

9 Global Burden Of Diabetes Prevalence and Projections 2010 and 2030 IDF, 2009.Prevalence

10 10 TOP 10 Number of people with diabetes (20-79 years) 2010 and 2030

11 11 T2DM trends in Egypt- Prevalence Prevalence (%) TotalMaleFemale Age Categories 42.6 % 8.8 % 20.3 % 28.3 % Egyptian Ministry of Health (MOH ) Preventive Sector, Central Epidemiology and Disease Surveillance (ESU) 2006

12 T2DM trends in Egypt Prevalence Insulin use Total OAD use Age Categories (%) Undiagnosed Egyptian Ministry of Health (MOH) Preventive Sector, Central Epidemiology and Disease Surveillance (ESU) 2006

13 T2DM trends in Egypt- Complications & Risk factors ( NIDE Data 2008 ) Neuropathy Nephropathy Retinopathy BMI < 25 BMI BMI > Hypertension Low HDL High Cholesterol Prevalence (%)

14 T2DM trends in Egypt-Metabolic Syndrome NIDE Data % of T2DM patients in Egypt have Metabolic Syndrome

15 T1DM trends in Egypt NIDE Data 2009 ( 852 Patients )

16 16 Hereditary factors

17 17 Infant feeding

18 18 Age of onset of diabetes

19 19 BMI in diabetic children

20 20 HbA1c among diabetic children

21 21 Beta cell function among diabetic children

22 22 Continues Home Blood Glucose Monitoring

23 MOH – Curative Care Sector Project: Early Detection of Diabetes Mellitus Salah El-Ghazaly Harb*, Ibrahim El-Ebrashy***, Mohamed Fahmy** and Madiha Said Abdel-Razik* Faculty of Medicine Cairo* and Ain Shams** Universities and the National Institute For Diabetes & Endocrinology***

24 The EDDP established "early detection of DM clinics (EDDMC) in 14 hospitals, in three phases. These hospitals are located in 12 governorates and distributed in the three Egypt Regions (Urban governorates, Lower Egypt and Upper Egypt). Throughout the period , more than at-risk 25 years of age individuals (hypertension, obesity, and positive family history of diabetes), but with negative history of DM had been examined.

25

26

27 27 Country profile Percent with diabetes (20-79 years), 2010 (national) 10.4 Percent with diabetes (20-79 years), 2010 (comparative) 11.4 Percent with diabetes (20-79 years), 2030 (comparative) 13.7 Number of people with diabetes, ,787,100 Egypt

28 Percent with impaired glucose tolerance (20-79 years), 2010 (national) 4.8 Percent with impaired glucose tolerance (20-79 years), 2010 (comparative) 5.1 New cases of type 1 diabetes in children (under 14 years) 2010 (new cases per 100,000 population per year) 8.0 Deaths attributable to diabetes (20-79 years), ,116 Mean health expenditure per person with diabetes (USD), R=2,

29

30 T2DM trends in Egypt- Current treatment practice Guidelines followed Majority follow ADA, EASD & IDF guidelines local clinical practice recommendation since 2009 MOH. Management Practices All oral anti-diabetic drugs available Metformin remains the mainstay of treatment together with SUs. TZDs are prescribed after failure of Metformin and SUs. Newer agents like DPP-IV are launched in the market. All types of insulin and insulin analogues are available. National DPP is just launched

31 Thank You


Download ppt "Egyptian Perspective On Prediabetes & Diabetes Ibrahim El Ebrashy Prof. Of Internal Medicine & Diabetes Faculty Of Medicine-Cairo University Dean National."

Similar presentations


Ads by Google